The global market for Intravenous (IV) Solutions was valued at US$ 12200 million in the year 2024 and is projected to reach a revised size of US$ 17320 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Intravenous (IV) Solutions Market

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 77%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Solutions.

The Intravenous (IV) Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous (IV) Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous (IV) Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Intravenous (IV) Solutions Market Report

Report Metric	Details
Report Name	Intravenous (IV) Solutions Market
Accounted market size in year	US$ 12200 million
Forecasted market size in 2031	US$ 17320 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Peripheral Parenteral Nutrition Total Parenteral Nutrition
Segment by Application	Hospital & Clinics Ambulatory Home Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous (IV) Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Intravenous (IV) Solutions Market growing?

Ans: The Intravenous (IV) Solutions Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Intravenous (IV) Solutions Market size in 2031?

Ans: The Intravenous (IV) Solutions Market size in 2031 will be US$ 17320 million.

What is the market share of major companies in Intravenous (IV) Solutions Market?

Ans: Global top three manufacturers hold a share over 35%.

Who are the main players in the Intravenous (IV) Solutions Market report?

Ans: The main players in the Intravenous (IV) Solutions Market are ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain)

What are the Application segmentation covered in the Intravenous (IV) Solutions Market report?

Ans: The Applications covered in the Intravenous (IV) Solutions Market report are Hospital & Clinics, Ambulatory, Home Care

What are the Type segmentation covered in the Intravenous (IV) Solutions Market report?

Ans: The Types covered in the Intravenous (IV) Solutions Market report are Peripheral Parenteral Nutrition, Total Parenteral Nutrition

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Peripheral Parenteral Nutrition

1.2.3 Total Parenteral Nutrition

1.3 Market by Application

1.3.1 Global Intravenous (IV) Solutions Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital & Clinics

1.3.3 Ambulatory

1.3.4 Home Care

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intravenous (IV) Solutions Market Perspective (2020-2031)

2.2 Global Intravenous (IV) Solutions Growth Trends by Region

2.2.1 Global Intravenous (IV) Solutions Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Intravenous (IV) Solutions Historic Market Size by Region (2020-2025)

2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Region (2026-2031)

2.3 Intravenous (IV) Solutions Market Dynamics

2.3.1 Intravenous (IV) Solutions Industry Trends

2.3.2 Intravenous (IV) Solutions Market Drivers

2.3.3 Intravenous (IV) Solutions Market Challenges

2.3.4 Intravenous (IV) Solutions Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Intravenous (IV) Solutions Players by Revenue

3.1.1 Global Top Intravenous (IV) Solutions Players by Revenue (2020-2025)

3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2020-2025)

3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Intravenous (IV) Solutions Revenue

3.4 Global Intravenous (IV) Solutions Market Concentration Ratio

3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2024

3.5 Global Key Players of Intravenous (IV) Solutions Head office and Area Served

3.6 Global Key Players of Intravenous (IV) Solutions, Product and Application

3.7 Global Key Players of Intravenous (IV) Solutions, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Intravenous (IV) Solutions Breakdown Data by Type

4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2020-2025)

4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2026-2031)

5 Intravenous (IV) Solutions Breakdown Data by Application

5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2020-2025)

5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Intravenous (IV) Solutions Market Size (2020-2031)

6.2 North America Intravenous (IV) Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Intravenous (IV) Solutions Market Size by Country (2020-2025)

6.4 North America Intravenous (IV) Solutions Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Intravenous (IV) Solutions Market Size (2020-2031)

7.2 Europe Intravenous (IV) Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Intravenous (IV) Solutions Market Size by Country (2020-2025)

7.4 Europe Intravenous (IV) Solutions Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Intravenous (IV) Solutions Market Size (2020-2031)

8.2 Asia-Pacific Intravenous (IV) Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2020-2025)

8.4 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Intravenous (IV) Solutions Market Size (2020-2031)

9.2 Latin America Intravenous (IV) Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Intravenous (IV) Solutions Market Size by Country (2020-2025)

9.4 Latin America Intravenous (IV) Solutions Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Intravenous (IV) Solutions Market Size (2020-2031)

10.2 Middle East & Africa Intravenous (IV) Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2020-2025)

10.4 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ICU Medical Inc. (U.S.)

11.1.1 ICU Medical Inc. (U.S.) Company Details

11.1.2 ICU Medical Inc. (U.S.) Business Overview

11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction

11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.1.5 ICU Medical Inc. (U.S.) Recent Development

11.2 B. Braun Melsungen AG (Germany)

11.2.1 B. Braun Melsungen AG (Germany) Company Details

11.2.2 B. Braun Melsungen AG (Germany) Business Overview

11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction

11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.2.5 B. Braun Melsungen AG (Germany) Recent Development

11.3 Fresenius Kabi AG (Germany)

11.3.1 Fresenius Kabi AG (Germany) Company Details

11.3.2 Fresenius Kabi AG (Germany) Business Overview

11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction

11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.3.5 Fresenius Kabi AG (Germany) Recent Development

11.4 Baxter (U.S.)

11.4.1 Baxter (U.S.) Company Details

11.4.2 Baxter (U.S.) Business Overview

11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction

11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.4.5 Baxter (U.S.) Recent Development

11.5 Amanta Healthcare (India)

11.5.1 Amanta Healthcare (India) Company Details

11.5.2 Amanta Healthcare (India) Business Overview

11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction

11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.5.5 Amanta Healthcare (India) Recent Development

11.6 Terumo Medical Corporation (Tokyo)

11.6.1 Terumo Medical Corporation (Tokyo) Company Details

11.6.2 Terumo Medical Corporation (Tokyo) Business Overview

11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction

11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.6.5 Terumo Medical Corporation (Tokyo) Recent Development

11.7 Grifols S.A. (Spain)

11.7.1 Grifols S.A. (Spain) Company Details

11.7.2 Grifols S.A. (Spain) Business Overview

11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction

11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2020-2025)

11.7.5 Grifols S.A. (Spain) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ICU Medical Inc. (U.S.)

B. Braun Melsungen AG (Germany)

Fresenius Kabi AG (Germany)

Baxter (U.S.)

Amanta Healthcare (India)

Terumo Medical Corporation (Tokyo)

Grifols S.A. (Spain)

List of Tables

Table 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Peripheral Parenteral Nutrition

Table 3. Key Players of Total Parenteral Nutrition

Table 4. Global Intravenous (IV) Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Intravenous (IV) Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Intravenous (IV) Solutions Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Intravenous (IV) Solutions Market Share by Region (2020-2025)

Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Intravenous (IV) Solutions Market Share by Region (2026-2031)

Table 10. Intravenous (IV) Solutions Market Trends

Table 11. Intravenous (IV) Solutions Market Drivers

Table 12. Intravenous (IV) Solutions Market Challenges

Table 13. Intravenous (IV) Solutions Market Restraints

Table 14. Global Intravenous (IV) Solutions Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Intravenous (IV) Solutions Market Share by Players (2020-2025)

Table 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2024)

Table 17. Ranking of Global Top Intravenous (IV) Solutions Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Intravenous (IV) Solutions, Headquarters and Area Served

Table 20. Global Key Players of Intravenous (IV) Solutions, Product and Application

Table 21. Global Key Players of Intravenous (IV) Solutions, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Intravenous (IV) Solutions Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2020-2025)

Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2026-2031)

Table 27. Global Intravenous (IV) Solutions Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Intravenous (IV) Solutions Revenue Market Share by Application (2020-2025)

Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Intravenous (IV) Solutions Revenue Market Share by Application (2026-2031)

Table 31. North America Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Intravenous (IV) Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Intravenous (IV) Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Intravenous (IV) Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Intravenous (IV) Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Intravenous (IV) Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Intravenous (IV) Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Intravenous (IV) Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2026-2031) & (US$ Million)

Table 46. ICU Medical Inc. (U.S.) Company Details

Table 47. ICU Medical Inc. (U.S.) Business Overview

Table 48. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product

Table 49. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 50. ICU Medical Inc. (U.S.) Recent Development

Table 51. B. Braun Melsungen AG (Germany) Company Details

Table 52. B. Braun Melsungen AG (Germany) Business Overview

Table 53. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product

Table 54. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 55. B. Braun Melsungen AG (Germany) Recent Development

Table 56. Fresenius Kabi AG (Germany) Company Details

Table 57. Fresenius Kabi AG (Germany) Business Overview

Table 58. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product

Table 59. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 60. Fresenius Kabi AG (Germany) Recent Development

Table 61. Baxter (U.S.) Company Details

Table 62. Baxter (U.S.) Business Overview

Table 63. Baxter (U.S.) Intravenous (IV) Solutions Product

Table 64. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 65. Baxter (U.S.) Recent Development

Table 66. Amanta Healthcare (India) Company Details

Table 67. Amanta Healthcare (India) Business Overview

Table 68. Amanta Healthcare (India) Intravenous (IV) Solutions Product

Table 69. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 70. Amanta Healthcare (India) Recent Development

Table 71. Terumo Medical Corporation (Tokyo) Company Details

Table 72. Terumo Medical Corporation (Tokyo) Business Overview

Table 73. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product

Table 74. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 75. Terumo Medical Corporation (Tokyo) Recent Development

Table 76. Grifols S.A. (Spain) Company Details

Table 77. Grifols S.A. (Spain) Business Overview

Table 78. Grifols S.A. (Spain) Intravenous (IV) Solutions Product

Table 79. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2020-2025) & (US$ Million)

Table 80. Grifols S.A. (Spain) Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. Intravenous (IV) Solutions Picture

Figure 2. Global Intravenous (IV) Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intravenous (IV) Solutions Market Share by Type: 2024 VS 2031

Figure 4. Peripheral Parenteral Nutrition Features

Figure 5. Total Parenteral Nutrition Features

Figure 6. Global Intravenous (IV) Solutions Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Intravenous (IV) Solutions Market Share by Application: 2024 VS 2031

Figure 8. Hospital & Clinics Case Studies

Figure 9. Ambulatory Case Studies

Figure 10. Home Care Case Studies

Figure 11. Intravenous (IV) Solutions Report Years Considered

Figure 12. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Intravenous (IV) Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Intravenous (IV) Solutions Market Share by Region: 2024 VS 2031

Figure 15. Global Intravenous (IV) Solutions Market Share by Players in 2024

Figure 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2024

Figure 18. North America Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Intravenous (IV) Solutions Market Share by Country (2020-2031)

Figure 20. United States Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Intravenous (IV) Solutions Market Share by Country (2020-2031)

Figure 24. Germany Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Intravenous (IV) Solutions Market Share by Region (2020-2031)

Figure 32. China Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Intravenous (IV) Solutions Market Share by Country (2020-2031)

Figure 40. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Intravenous (IV) Solutions Market Share by Country (2020-2031)

Figure 44. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Intravenous (IV) Solutions Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 48. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 49. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 50. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 51. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 52. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 53. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39V17668

Mon Oct 13 00:00:00 UTC 2025

Add to Cart

Global Lipidomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-22L19757

Mon Oct 06 00:00:00 UTC 2025

Add to Cart

Global Spatial Transcriptomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-29Y19622

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Internet Intelligent Elderly Care Service Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-25O19660

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Intravenous (IV) Solutions Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-19E6062

Global Intravenous (IV) Solutions Market Research Report 2025

FEATURED COMPANIES

Intravenous (IV) Solutions Market Size

Intravenous (IV) Solutions Market

Scope of Intravenous (IV) Solutions Market Report

Chapter Outline

FAQ for this report

How fast is Intravenous (IV) Solutions Market growing?

What is the Intravenous (IV) Solutions Market size in 2031?

What is the market share of major companies in Intravenous (IV) Solutions Market?

Who are the main players in the Intravenous (IV) Solutions Market report?

What are the Application segmentation covered in the Intravenous (IV) Solutions Market report?

What are the Type segmentation covered in the Intravenous (IV) Solutions Market report?

FEATURED COMPANIES

RELATED REPORTS

Parenteral Nutrition Market

Single User,